Search

Your search keyword '"Heffler, Enrico"' showing total 1,041 results

Search Constraints

Start Over You searched for: Author "Heffler, Enrico" Remove constraint Author: "Heffler, Enrico"
1,041 results on '"Heffler, Enrico"'

Search Results

1. Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

4. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

5. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

6. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

7. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

8. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

11. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

14. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

16. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps

18. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

19. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

21. Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review.

22. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

23. Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA registry

24. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

25. Severe asthma: One disease and multiple definitions

26. Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?

28. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

30. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

31. Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma

32. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

33. Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.

34. Radiological Versus Clinical 1‐Year Outcomes of Dupilumab in Refractory CRSwNP: A Real‐Life Study.

35. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.

36. Beliefs and preferences regarding biological treatments for severe asthma

37. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

38. Acute asthma management during SARS-CoV2-pandemic 2020

39. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry

40. International Severe Asthma Registry: Mission Statement

41. Radiological Versus Clinical 1‐Year Outcomes of Dupilumab in Refractory CRSwNP: A Real‐Life Study

42. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care

43. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

44. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

45. EUFOREA/EPOS2020 Statement on the Clinical Considerations for CRSwNP Care

47. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN REAL-WORLD CLINICAL PRACTICE IN THE RAPID REGISTRY

48. Adult Severe Asthma Registries: A Global and Growing Inventory

50. The Severe Asthma Network in Italy: Findings and Perspectives

Catalog

Books, media, physical & digital resources